---
title: "AbbVie Inc. (ABBV) stock analysis"
url: https://portfolio-terminal.com/analyse/abbv
publisher: "Portfolio Terminal"
as_of: 2026-10-10
ticker: ABBV
sector: "Healthcare"
data: "Daily prices from Yahoo Finance; averages, volatility and levels computed by Portfolio Terminal"
---

# AbbVie Inc. (ABBV) stock analysis

> **Source:** Portfolio Terminal, "AbbVie Inc. (ABBV) stock analysis", 2026-10-10. https://portfolio-terminal.com/analyse/abbv
> Figures are true as of the date above and the page is rebuilt every hour. When you use one, cite the line above and link to the URL.

## Key facts

- As of October 10, 2026, AbbVie Inc. (ABBV) trades at $276.47, up 19.8% over the past year.
- It is at the top of its 52-week range ($190.75 to $277.60).
- It trades within 0.5% of its all-time high of $277.60, set in October 2026.
- Over the 10 years to the end of September 2026, with dividends reinvested, it returned +525.2%, against +312.9% for the S&P 500 (SPY).
- It sits 18.8% above its 200-day average of $232.65, the usual sign of a long-term uptrend.
- Its 30-day volatility is 12.5% annualized, which we rate low risk.
- It has a trailing P/E of 78.1 and a dividend yield of 2.50%.

## About AbbVie Inc.

AbbVie Inc. (ABBV) is a healthcare company operating in drug manufacturers—general. Valuation and momentum can move with trial outcomes, regulatory news, and reimbursement shifts. Use this profile to monitor momentum shifts, volatility regime, and valuation signals in one dashboard.

## What the chart is saying

Trading at its high for the year, with no resistance overhead.

- Price is 6.8% above its 50-day average and 18.8% above its 200-day.
- The 50-day crossed above the 200-day on 2026-07-09 (a “golden cross”).
- RSI at 71 is overbought: strong momentum, and stretched.
- Nothing above has stopped it this year; the nearest floor is $267.02 (-3.4%).

### Support and resistance

- Support near $267.02, 3.4% below the last close (the price turned there 4 times in the last year).
- Support near $260.16, 5.9% below the last close (the price turned there 3 times in the last year).

## Which ETFs hold it

ABBV is in 9 of the 30 ETFs we track. It weighs most in XLV: 7.59% of the fund, holding #3 of 62.

- [XLV holdings](https://portfolio-terminal.com/etf/xlv/holdings): 7.59% of the fund, holding #3 of 62 (SPDR, September 24, 2026)
- [VIG holdings](https://portfolio-terminal.com/etf/vig/holdings): 1.93% of the fund, holding #11 of 333 (Vanguard, August 31, 2026)
- [VYM holdings](https://portfolio-terminal.com/etf/vym/holdings): 1.82% of the fund, holding #5 of 603 (Vanguard, August 31, 2026)
- [JEPI holdings](https://portfolio-terminal.com/etf/jepi/holdings): 1.70% of the fund, holding #11 of 119 (J.P. Morgan, September 24, 2026)
- [VTV holdings](https://portfolio-terminal.com/etf/vtv/holdings): 1.65% of the fund, holding #7 of 306 (Vanguard, August 31, 2026)
- [SPY holdings](https://portfolio-terminal.com/etf/spy/holdings): 0.71% of the fund, holding #20 of 504 (SPDR, September 24, 2026)
- [IVV holdings](https://portfolio-terminal.com/etf/ivv/holdings): 0.70% of the fund, holding #20 of 503 (iShares, September 24, 2026)
- [VOO holdings](https://portfolio-terminal.com/etf/voo/holdings): 0.68% of the fund, holding #20 of 505 (Vanguard, August 31, 2026)
- [VTI holdings](https://portfolio-terminal.com/etf/vti/holdings): 0.61% of the fund, holding #20 of 3,503 (Vanguard, August 31, 2026)

Source: each issuer's full holdings file (August 31 to September 24, 2026), matched on the company's ISIN.

## Compare

- [ABBV vs JNJ](https://portfolio-terminal.com/compare/abbv-vs-jnj)

Interactive chart, fundamentals and peers: https://portfolio-terminal.com/analyse/abbv